We have shown previously that 1-month postinfection, the neutralizing activity of circulating antibodies and the level of serum IgA against SARS-CoV-2 were higher in MIS-C patients compared with children with uncomplicated COVID-19.2 In contrast, no difference was observed in the levels of IgG and IgM antibodies. This evidence concerns the gene CD79A and COVID-19.